AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and services provider established in 1975. The acquisition deepens AscellaHealth’s capabilities to serve international manufacturers and patients in more than 70 countries across the EU, Asia, Africa, Australia and the Americas.
“The integration of CHAPPER healthcare into the AscellaHealth organization consolidates overall global market leadership, unlocking new opportunities for market access and product commercialization throughout the global life sciences industry,” says Bill Oldham, chairman and president, AscellaHealth. “Our combined experience, expertise and capabilities strengthen the AscellaHealth customer value proposition for delivering innovative, end-to-end solutions and providing our market-leading patient support programs throughout the world.”
Complementing the AscellaHealth global reputation as a trusted partner in the pharmaceutical industry, CHAPPER healthcare specializes in the import and export of direct to hospital and non-registered medicines, with a specialty pharmacy to meet diverse market needs.
Mario Patone, CFO, AscellaHealth, adds: “A strategic transaction in the U.K. with access to global markets underscores our shared commitment to shaping the future of healthcare, driving business growth and expanding our international presence. This acquisition will significantly accelerate the global market reach and operational scale of both organizations.”
CHAPPER healthcare is also a founding member of EUROPACCESS, a partnership of seven European Companies (Ilapo, Intsel Chimos, Tetrago, Pharma International, Lenis and Euraxi), providing streamlined and faster access to European healthcare systems by supporting its manufacturer partners in the distribution of their medicines. Service offerings span the drug lifecycle from early access, through dossier filing to post-marketing authorization distribution.
Jonathan Chapper, CEO, CHAPPER healthcare, says: “We are excited about the opportunity to join forces with the impressive AscellaHealth team and advance global access to vital medicines, particularly in times of urgent need. This is an opportunity to further strengthen our international market impact and serve the expanding AscellaHealth partner portfolio. Together, we are positioned to accelerate our mission of breaking down barriers to care while driving meaningful and sustainable advancements in the global specialty pharmaceutical landscape.”
